DM

Deepali Mahajan

Active Director Director DIN 11347963
DIN 11347963 First appointment Oct 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Deepali Mahajan

Data last updated:

Deepali Mahajan is a Director at Cellopharma Research Private Limited (since 2025). The company operates in Pharma.

DIN 11347963
Primary Designation Director
Industry Pharma
First Appointment 18 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cellopharma Research Private Limited U47721PB2025PTC066069
Director18 Oct 20252025Active

Board colleagues of Deepali Mahajan

Directorship timeline

Open interactive timeline →
Cellopharma Research Private Limited
Premium access

Shareholding and investment profile for Deepali Mahajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepali Mahajan

Deepali Mahajan currently holds 1 directorship: Cellopharma Research Private Limited (Director, since 18 Oct 2025).

Deepali Mahajan was first appointed on 18 Oct 2025 as Director at Cellopharma Research Private Limited.

The current boards of Deepali Mahajan's companies include Inam Ur Rehman (Cellopharma Research Private Limited), Kavita Mahajan (Cellopharma Research Private Limited), Sahil Mahajan (Cellopharma Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available